Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori glycosidase refers to a group of enzymes produced by the bacterium Helicobacter pylori that catalyze the hydrolysis of glycosidic bonds in complex carbohydrates (Source: PubMed, PMID: 15657238). These enzymes, including alpha-L-fucosidases and peptidoglycan hydrolases, are essential for the bacterium's ability to colonize the human gastric mucosa and maintain cell wall integrity (Source: UniProt, P0C680). By cleaving fucose from host Lewis antigens, the bacterium can utilize host sugars as a nutrient source and facilitate adhesion to the stomach lining (Source: Journal of Biological Chemistry, doi:10.1074/jbc.M411143200). In addition, glycosidases involved in peptidoglycan turnover are critical for bacterial growth and division, making them attractive targets for novel antimicrobial therapy (Source: Microbiology, doi:10.1099/mic.0.2006/001859-0). Targeting these enzymes with specific inhibitors, such as iminosugars like deoxyfuconojirimycin, has shown potential in reducing bacterial fitness and virulence in preclinical studies (Source: Bioorganic & Medicinal Chemistry, doi:10.1016/j.bmc.2010.06.098). As antibiotic resistance in H. pylori becomes a global health concern, these glycosidases represent a promising avenue for developing non-traditional treatments that disrupt the pathogen's metabolic and structural stability (Source: World Journal of Gastroenterology, doi:10.3748/wjg.v20.i30.10212).
Competitive inhibition of bacterial glycoside hydrolases, preventing the cleavage of host-derived glycans and disrupting bacterial cell wall remodeling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori glycosidase.